NCT02015299View on ClinicalTrials.gov

Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2016

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Linagliptin

one tablet linagliptin 5 mg/day for 26 weeks

DRUG

placebo

one tablet matching placebo/day for 26 weeks

Trial Locations (1)

9700 RB

University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

dr. DJ Mulder

OTHER